Non-receptor Tyrosine Kinases c-Abl and Arg Regulate the Activity of C/EBPβ

Journal of Molecular Biology

Volumn 391, Issue 4, 2009, Pages 729-743

  Li, Xiaorong ^a,b   Liu, Xuan ^a   Wang, Guangfei ^a   Zhu, Xiaohui ^a   Qu, Xiuhua ^a   Li, Xiaoming ^a   Yang, Yao ^a   Peng, Li ^a   Li, Chufang ^a   Li, Ping ^a   Huang, Wei ^a   Ma, Qingjun ^a   Cao, Cheng ^a  

^a BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

^b SOUTHWEST UNIVERSITY   (China)

Author keywords

apoptosis; Arg; c Abl; C EBP ; tyrosine kinase

Indexed keywords

ABELSON KINASE; AMINO ACID; ARGININE; CCAAT ENHANCER BINDING PROTEIN BETA; MUTANT PROTEIN; PROTEIN TYROSINE KINASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CONTROLLED STUDY; EMBRYO; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; WILD TYPE;

MURINAE;

EID: 68149178654     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2009.06.055     Document Type: Article

References (56)

1. Akira S., Isshiki H., Sugita H., Tanabe O., Kinoshita S., and Nishio Y. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J. 9 (1990) 1897-1906
2. Isshiki H., Akira S., Tanabe O., Nakajima T., Shimamoto T., Hirano T., and Kishimoto T. Constitutive and IL-1 inducible factors interact with the IL-1 responsive element in the IL-6 gene. Mol. Cell Biol. 10 (1990) 2757-2764
3. Akira S. IL-6-regulated transcription factors. Int. J. Biochem. Cell Biol. 9 (1997) 1401-1418
4. Lekstrom-Himes J., and Xanthopoulos KG. Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J. Biol. Chem. 273 (1998) 28545-28548
5. Ramji D.P., and Foka P. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem. J. 365 (2002) 561-575
6. Williams S.C., Baer M., Dillner A.J., and Johnson P.F. CRP2 (C/EBPb) contains a bipartite regulatory domain that controls transcriptional activation, DNA binding and cell specificity. EMBO J. 1b4 (1995) 3170-3183
7. Pei D.Q., and Shih C.H. An "attenuator domain" is sandwiched by two distinct transactivation domains in the transcription factor C/EBP. Mol. Cell Biol. 11 (1991) 1480-1487
8. Kowenz-Leutz E., Twamley G., Ansieau S., and Leutz A. Novel mechanism of C/EBPb (NF-M) transcriptional control : activation through derepression. Genes Dev. 8 (1994) 2781-2791
9. Dearth L.R., Hutt J., Sattler A., Gigliotti A., and DeWille J. Expression and function of CCAAT/enhancer binding proteinbeta (C/EBPbeta) LAP and LIP isoforms in mouse mammary gland, tumors and cultured mammary epithelial cells. J. Cell Biochem. 82 (2001) 357-370
10. Gheorghiu I., Deschenes C., Blais M., Boudreau F., Rivard N., and Asselin C. Role of specific CCAAT/enhancer-binding protein isoforms in intestinal epithelial cells. J. Biol. Chem. 276 (2001) 44331-44337
11. Luedde T., Duderstadt M., Streetz K.L., Tacke F., Kubicka S., Manns M.P., and Trautwein C. C/EBP beta isoforms LIP and LAP modulate progression of the cell cycle in the regenerating mouse liver. Hepatology 40 (2004) 356-365
12. Buck M., Poli V., Hunter T., and Chojkier M. C/EBPbeta phosphorylation by RSK creates a functional XEXD caspase inhibitory box critical for cell survival. Mol. Cell 8 (2001) 807-816
13. Metz R., and Ziff E. cAMP stimulates the C/EBP-related transcription factor rNFIL-6 to trans-locate to the nucleus and induce c-fos transcription. Genes Dev. 5 (1991) 1754-1766
14. Wegner M., and Cao Z. Rosenfeld MG. Calcium-regulated phosphorylation within the leucine zipper of C/EBPb. Science 256 (1992) 370-373
15. Nakajima T., Kinoshita S., Sasagawa T., Sasaki K., Naruto M., Kishimoto T., and Akira S. Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6. Proc. Natl Acad. Sci. USA 90 (1993) 2207-2211
16. Buck M., Poli V., van der Geer P., Chojkier M., and Hunter T. Phosphorylation of rat serine 105 or mouse threonine 217 in C/EBPβ is required for hepatocyte proliferation induced by TGFa. Mol. Cell 4 (1999) 1087-1092
17. Shuman J.D., Sebastian T., Kaldis P., Copeland T.D., Zhu S., Smart R.C., and Johnson P.F. Cell cycle-dependent phosphorylation of C/EBPbeta mediates oncogenic cooperativity between C/EBPbeta and H-RasV12. Mol. Cell Biol. 24 (2004) 7380-7391
18. Zhao X., Zhuang S., Chen Y., Boss G.R., and Pilz R.B. Cyclic GMP-dependent protein kinase regulates CCAAT enhancer-binding protein beta functions through inhibition of glycogen synthase kinase-3. J. Biol. Chem. 280 (2005) 32683-32692
19. Goff S., Gilboa E., Witte O., and Baltimore D. Structure of the Abelson murine leukemia virus genome and the homologous cellular gene studies with cloned viral DNA. Cell 22 (1980) 777-785
20. Kruh G.D., Perego R., Miki T., and Aaronson S.S. The complete coding sequence of arg defines the Abelson subfamily of cytoplasmic tyrosine kinases. Proc. Natl Acad. Sci. USA 87 (1990) 5802-5806
21. Pendergast A.M. The Abl family kinases: mechanisms of regulation and signaling. Adv. Cancer Res. 85 (2002) 51-100
22. Ren R., Mayer B., Cicchetti P., and Baltimore D. Identification of a ten-amino acid proline-rich SH3 binding site. Science 259 (1993) 1157-1161
23. Shaul Y. c-Abl: activation and nuclear targets. Cell Death Diff. 7 (2000) 1-16
24. Van Etten R.A. Cycling, stressed out and nervous: Cellular functions of c-Abl. Trends Cell Biol. 9 (1999) 179-186
25. Koleske A.J., Gifford A.M., Scott M.L., Nee M., Bronson R.T., Miczek K.A., and Baltimore D. Essential roles for the Abl and Arg tyrosine kinases in neurulation. Neuron 21 (1998) 1259-1272
26. Welch P.J., and Wang J.Y. A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle. Cell 75 (1993) 779-790
27. Sawyers C.L., McLaughlin J., Goga A., Havlik M., and Witte O. The nuclear tyrosine kinase c-Abl negatively regulates cell growth. Cell 77 (1994) 121-131
28. Lamb J., Ramaswamy S., Ford H.L., Contreras B., Martinez R.V., Kittrell F.S., et al. A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 114 (2003) 323-334
29. Sebastian T., Malik R., Thomas S., Sage J., and Johnson P.F. C/EBPb cooperates with RB:E2F to implement RasV12-induced cellular senescence. The EMBO J. 24 (2005) 3301-3312
30. Johnson P.F. Molecular stop signs: regulation of cell-cycle arrest by C/EBP transcription factors. J. Cell Sci. 118 (2005) 2545-2555
31. Buck M., Turler H., and Chojkier M. LAP (NF-IL-6), a tissue-specific transcriptional activator, is an inhibitor of hepatoma cell proliferation. EMBO J. 13 (1994) 851-860
32. Cortes-Canteli M., Pignatelli M., Santos A., and Perez-Castillo A. CCAAT/enhancer binding protein plays a regulatory role in differentiation and apoptosis of neuroblastoma cells. J. Biol. Chem. 277 (2002) 5460-5467
33. Mukherjee D., Kaestner K.H., Kovalovich K.K., and Greenbaum L.E. Fas-induced apoptosis in mouse hepatocytes is dependent on C/EBPbeta. Hepatology 33 (2001) 1166-1172
34. Phizicky E.M., and Fields S. Protein-protein interactions: methods for detection and analysis. Microbiol. Rev. 59 (1995) 94-123
35. Nagar B., Hantschel O., Young M.A., Scheffzek K., Veach D., Bornmann W., et al. Structural basis for the autoinhibition of c-Abl tyrosine kinase. Cell 112 (2003) 859-871
36. Hantschel O., Nagar B., Guettler S., Kretzschmar J., Dorey K., Kuriyan J., et al. A myristoyl/phosphotyrosine switch regulates c-Abl. Cell 112 (2003) 845-857
37. Hantschel O., and Superti-Furga G. Regulation of the c-Abl and Bcr-Abl tyrosine kinases. Nature Rev. Mol. Biolo. 5 (2004) 33-44
38. Patel H., Marley S.B., Greener L., and Gordon M.Y. Subcellular distribution of p210BCR-ABL in CML cell lines and primary CD34t CML cells. Leukemia 22 (2008) 559-571
39. Bradley M.N., Zhou L., and Smale S.T. C/EBPβregulation in Lipopolysaccharide-Stimulated Macrophages. Mol. Cell Biol. 23 (2003) 4841-4858
40. Piwien-Pilipuk G., MacDougald O., and Schwartz J. Dual regulation of phosphorylation and dephosphorylation of C/EBPbeta modulate its transcriptional activation and DNA binding in response to growth hormone. J. Biol. Chem. 277 (2002) 44557-44565
41. Bundy L.M., and Sealy L. CCAAT/enhancer binding protein beta (C/EBPbeta)-2 transforms normal mammary epithelial cells and induces epithelial to mesenchymal transition in culture. Oncogene 22 (2003) 869-883
42. Sterneck E., Zhu S., Ramirez A., Jorcano J.L., and Smart R.C. Conditional ablation of C/EBP beta demonstrates its keratinocyte-specific requirement for cell survival and mouse skin tumorigenesis. Oncogene 25 (2006) 1272-1276
43. Wessells J., Yakar S., and Johnson P.F. Critical prosurvival roles for C/EBP beta and insulin-like growth factor I in macrophage tumor cells. Mol. Cell Biol. 24 (2004) 3238-3250
44. Buck M., and Chojkier M. Signal transduction in the liver: C/EBPbeta modulates cell proliferation and survival. Hepatology 37 (2003) 731-738
45. Duprez E. A new role for C/EBPbeta in acute promyelocytic leukemia. Cell Cycle 3 (2004) 389-390
46. Guerzoni C., Bardino M., Mariani S.A., Ferrari-Amorotti G., Neviani P., Panno M.L., et al. Inducible activation of CEBPB, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BCR/ABL-expressing cells. Blood 107 (2006) 4080-4089
47. Sebastian T., and Johnson P.F. Stop and go: anti-proliferative and mitogenic functions of the transcription factor C/EBPbeta. Cell Cycle 5 (2006) 953-957
48. Zahnow C.A., Younes P., Laucirica R., and Rosen J.M. Overexpression of C/EBPbeta-LIP, a naturally occurring, dominant-negative transcription factor, in human breast cancer. J. Natl Cancer Inst. 89 (1997) 1887-1891
49. Zhu S., Oh H.S., Shim M., Sterneck E., Johnson P.F., and Smart R.C. C/EBPbeta modulates the early events of keratinocyte differentiation involving growth arrest and keratin 1 and keratin 10 expression. Mol. Cell Biol. 19 (1999) 7181-7190
50. Mink S., Haenig B., and Klempnauer K.H. Interaction and functional collaboration of p300 and C/EBPbeta. Mol. Cell Biol. 17 (1997) 6609-6617
51. Wang H., Larris B., Peiris T.H., Zhang L., Le Lay J., Gao Y., and Greenbaum L. C/EBPbeta activates E2F-regulated genes in vivo via recruitment of the coactivator CREB-binding protein/P300. J. Biol. Chem. 282 (2007) 24679-24688
52. Yoon K., Zhu S., Ewing S.J., and Smart R.C. Decreased survival of C/EBP beta-deficient keratinocytes is due to aberrant regulation of p53 levels and function. Oncogene 26 (2006) 360-367
53. Ewing S.J., Zhu S., Zhu F., House J.S., and Smart R.C. C/EBPbeta represses p53 to promote cell survival downstream of DNA damage independent of oncogenic Ras and p19(Arf). Cell Death Differ. 15 (2008) 1734-1744
54. Ranjan P., and Boss J.M. C/EBPbeta regulates TNF induced MnSOD expression and protection against apoptosis. Apoptosis 11 (2006) 1837-1849
55. Buck M., and Chojkier M. A ribosomal S-6 kinase-mediated signal to C/EBP-beta is critical for the development of liver fibrosis. PLoS ONE. 2 (2007) e1372
56. Li Y., Bevilacqua E., Chiribau C.B., Majumder M., Wang C., Croniger C.M., et al. Differential control of the CCAAT/enhancer-binding protein beta (C/EBPbeta) products liver-enriched transcriptional activating protein (LAP) and liver-enriched transcriptional inhibitory protein (LIP) and the regulation of gene expression during the response to endoplasmic reticulum stress. J. Biol. Chem. 283 (2007) 22443-22456